Evidence map›Paper›PMID 27453951›Full record

ArticleJCI insight2016

An extra copy of

Everett J Moding, Hooney D Min, Katherine D Castle, Moiez Ali, Loretta Woodlief, Nerissa Williams, Yan Ma, Yongbaek Kim, Chang-Lung Lee, David G Kirsch

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Role of p53 in Regulating Radiation Responses.Life (Basel, Switzerland) · 2022
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Everett J ModingDepartment of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, USA.
Hooney D MinDepartment of Radiation Oncology, Duke University, Durham, North Carolina, USA.
Katherine D CastleDepartment of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, USA.
Moiez AliDepartment of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, USA.
Loretta WoodliefDepartment of Radiation Oncology, Duke University, Durham, North Carolina, USA.
Nerissa WilliamsDepartment of Radiation Oncology, Duke University, Durham, North Carolina, USA.
Yan MaDepartment of Radiation Oncology, Duke University, Durham, North Carolina, USA.
Yongbaek KimLaboratory of Veterinary Clinical Pathology, College of Veterinary Medicine, Seoul National University, Seoul, South Korea.
Chang-Lung LeeDepartment of Radiation Oncology, Duke University, Durham, North Carolina, USA.
David G KirschDepartment of Pharmacology and Cancer Biology, Duke University, Durham, North Carolina, USA; Department of Radiation Oncology, Duke University, Durham, North Carolina, USA.
Duke University · USSeoul National University · KR

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Defining the cellular target of radiotherapy in primary mouse models of cancerF30CA177220 · NCI · DUKE UNIVERSITY · PI MODING, EVERETT JAMES · 2013 to 2014
$79k
NCI NIH HHS F30 CA177220NIGMS NIH HHS T32 GM007171
6 · The paper itself

Abstract

The tumor suppressor p53 blocks tumor progression in multiple tumor types. Radiation-induced cancer following exposure to radiation therapy or space travel may also be regulated by p53 because p53 has been proposed to respond to DNA damage to suppress tumorigenesis. Here, we investigate the role of p53 in lung carcinogenesis and lymphomagenesis in

Identifiers

PMID27453951
PMCPMC4955525
OpenAlexW2461707429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.